MEDULLOBLASTOMA IN ADULTS - SURVIVAL AND PROGNOSTIC FACTORS

被引：35

作者：

CARRIE, C ^{[1
]}

LASSET, C ^{[1
]}

BLAY, JY ^{[1
]}

NEGRIER, S ^{[1
]}

BOUFFET, E ^{[1
]}

BARBET, N ^{[1
]}

MONTBARBON, X ^{[1
]}

WAGNER, JP ^{[1
]}

LAPRAS, C ^{[1
]}

DERUTY, R ^{[1
]}

MOTTOLESE, C ^{[1
]}

SINDOU, M ^{[1
]}

BRET, P ^{[1
]}

LACROZE, M ^{[1
]}

MORNEX, F ^{[1
]}

BRUNATMENTIGNY, M ^{[1
]}

BIRON, P ^{[1
]}

机构：

[1] HOP NEUROL,F-69500 BRON,FRANCE

来源：

RADIOTHERAPY AND ONCOLOGY | 1993年 / 29卷 / 03期

关键词：

MEDULLOBLASTOMA; ADULTS; SURVIVAL; PROGNOSIS; CHEMOTHERAPY; RADIOTHERAPY;

D O I：

10.1016/0167-8140(93)90148-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The authors report a series of 30 adults with medulloblastoma treated after surgery between 1975 and 1990. Half the patients presented a classical medulloblastoma and the other half presented desmoplastic medulloblastoma. Brainstem infiltration was noted in 3 patients, cerebellar peduncle infiltration in 6 cases and 4 patients had cerebrospinal fluid (CSF) involvement. Tumor resection was achieved in all patients except 1, and in 5 surgery was incomplete. All patients but 2 received postoperative cerebral radiotherapy. Six patients did not receive chemotherapy before radiotherapy, 7 patients received CCNU-Vincristine concomitantly with and after irradiation, 1 patient was given a CHOP regimen, and the remaining 16 patients received the 8 drugs in a 1-day (8/1) regimen before irradiation. The median follow-up time was 104 months. The 5- and 10-year overall survival rates were 58.5% and 41%, respectively. Two toxic deaths occurred under the 8/1 regimen, and no better survival was observed for this group of patients in comparison with those receiving other regimens. Persistance of malignant cells in the CSF, brainstem involvement, cerebellar peduncle infiltration, non-radical surgery and a postoperative performance status (PS) of more than 2 were significantly correlated with an adverse outcome for overall survival in adult patients with medulloblastoma.

引用

页码：301 / 307

页数：7

共 20 条

[1] Bernard, Brunat-Mentigny, Tron, Rocher, Frappaz, Thyss, Quintana, Early chemotherapy including 8/1 regimen and high dose MTX for newly diagnosed medulloblastoma: a report of 75 patients treated on the M7. French cooperative protocol, Pediatr. Neuro. Sci., 14, (1988)
[2] Bloom, Bessell, Medulloblastoma in adults: a review of 47 patients treated between 1952 and 1981, Int. J. Radiat. Oncol., Biol. Phys., 18, pp. 763-772, (1990)
[3] Burgers, Voute, Kracher, Oldenburger, Treatment results of medulloblastoma from 1976–1988, Med. Pediatr. Oncol., 19, (1991)
[4] Carrie, Alapetite, Mere, Aimard, Pons, Kolodie, Seng, Lagrange, Pontvert, Pignon, Lacroze, Ginestet, Bernard, Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: the contribution of radiotherapy technique to tumours relapse, Radiother. Oncol., 24, pp. 77-81, (1991)
[5] Evans, Kramer, Chang, Leikin, Hammlond, The treatment of medulloblastoma. Results of a randomized trial of radiation therapy with and without CCNU-Vincristine and Prednisone, J. Neurosurg., 72, pp. 572-582, (1990)
[6] Haie, Schlinger, Constans, Meder, Reynaud, Ghenim, Results of radiation treatment of medulloblastoma in adults, Int. J. Radiat. Oncol., Biol. Phys., 11, pp. 2051-2056, (1985)
[7] Halberg, Wara, Fippin, Edwards, Levin, Davis, Prados, Wilson, Low dose craniospinal radiation therapy for medulloblastoma, Int. J. Radiat. Oncol., Biol. Phys., 20, pp. 651-652, (1991)
[8] Her Shatter, Halperin, Cox, Medulloblastoma the Duke university medical center experience, International Journal of Radiation Oncology*Biology*Physics, 12, pp. 1771-1777, (1986)
[9] I.C.R.U. International Commission on Radiation Units and Measurements, Dose specification for reporting external beam therapy with photons and electrons, I.C.R.U. Report 29, (1978)
[10] Jereb, Sundaresan, Horten, Reid, Galicich, Supratentorial recurrences in medulloblastoma, Cancer, 47, pp. 806-809, (1981)

← 1 2 →